Clinical Trials Browser

Interventional × Rectal Neoplasms × Patient Reported Outcome Measures × Clear all

NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Phase 2 Unknown

Gastrointestinal

Fatigue, Rectal Neoplasms